Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Special Dividend

3 Dec 2020 07:05

RNS Number : 3479H
Braveheart Investment Group plc
03 December 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

3 December 2020

Braveheart Investment Group plc

("Braveheart" or the "Company")

Special Dividend

 

In the interim results for the six months ended 30 September 2020, the board of Braveheart (the "Board") announced that it had declared the payment of a special interim dividend of 42.75 pence per Ordinary Share (the "Special Dividend") which with the current issued share capital of the Company being 36,252,748 equates to a total dividend of approximately £15.5 million.

As at 30 November 2020, the Company and its subsidiaries (the "Group") had net cash reserves of approximately £18.15 million. The Board has assessed the Group's ongoing working capital and investment cash requirements under a range of forecast scenarios and has concluded that a substantial portion of these cash reserves is surplus to the Group's requirements. The Board has, therefore, decided to return such surplus capital to Braveheart shareholders by way of the Special Dividend.

The Company intends to pay the Special Dividend on 6 January 2021 to Braveheart shareholders on the register on 11 December 2020. The Ordinary Shares will be marked ex dividend on 10 December 2020. The Special Dividend will be funded from the Company's existing cash balances.

The Company will be filing at Companies House interim accounts for the period ending 30 November 2020 in accordance with the Companies Act 2006 requirements.

For further information: 

 

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

 

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Hornigold

 

 

 

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBIBDDGBGDGGD
Date   Source Headline
27th Jun 20228:40 amRNSDirector/PDMR Shareholding
16th Jun 20227:00 amRNSFinal Results
9th May 20223:57 pmRNSReplacement - Cancellation and grant of options
9th May 20221:08 pmRNSCancellation and grant of options
29th Apr 20225:00 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSPlacing to raise £215,113
31st Mar 202212:17 pmRNSResult of General Meeting
28th Mar 20229:42 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSNotice of GM and authority to issue shares
14th Mar 202211:23 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSBlock admission six monthly return
8th Mar 20229:41 amRNSDirector/PDMR Shareholding
25th Feb 202211:06 amRNSSecond Price Monitoring Extn
25th Feb 202211:00 amRNSPrice Monitoring Extension
25th Feb 20227:00 amRNSOperational update
31st Jan 20227:00 amRNSHolding(s) in Company
28th Jan 20221:55 pmRNSHolding(s) in Company
21st Jan 20222:46 pmRNSOperational update on Paraytec
17th Jan 20223:23 pmRNSFurther re. Director/PDMR holding
17th Jan 20229:24 amRNSHolding(s) in Company
16th Dec 20217:00 amRNSNon Regulatory - PhaseFocus Update
8th Dec 20214:08 pmRNSDirector/PDMR Shareholding
8th Dec 20217:00 amRNSOperational update on Paraytec
26th Nov 20219:49 amRNSVideo from The University of Sheffield re Paraytec
15th Nov 20217:00 amRNSHalf-year Report
14th Oct 20211:46 pmRNSDirector/PDMR Shareholding
11th Oct 202111:02 amRNSHolding(s) in Company
11th Oct 20217:30 amRNSInvestment in Autins Group plc
30th Sep 20215:00 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSOperational update on various investments
28th Sep 202112:14 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSBlock admission six monthly return
31st Aug 20215:00 pmRNSTotal Voting Rights
13th Aug 202111:05 amRNSSecond Price Monitoring Extn
13th Aug 202111:00 amRNSPrice Monitoring Extension
13th Aug 20217:00 amRNSPlacing to raise £2.5 million
6th Aug 202111:05 amRNSSecond Price Monitoring Extn
6th Aug 202111:00 amRNSPrice Monitoring Extension
4th Aug 20212:40 pmRNSFurther update re Paraytec AD Scanner project
26th Jul 20215:49 pmRNSDirector/PDMR Shareholding
14th Jul 20212:37 pmRNSResult of AGM
29th Jun 20214:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20217:49 amRNSFurther update re Paraytec Limited
18th Jun 20217:00 amRNSFinal Results
16th Jun 20217:00 amRNSAppointment of Non-Executive Director
14th Jun 20219:40 amRNSUpdate on the Paraytec AD Scanner project
9th Jun 20217:01 amRNSDisposal of interest in Gyrometric Systems Limited
8th Jun 20215:25 pmRNSBlock admission six monthly return
28th May 20215:00 pmRNSTotal Voting Rights
18th May 20217:00 amRNSExercise of Employee Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.